We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$191M
AUM Growth
-$20.5M
Cap. Flow
-$12.4M
Cap. Flow %
-6.5%
Top 10 Hldgs %
8%
Holding
450
New
8
Increased
100
Reduced
215
Closed
125

Top Buys

Rank Stock Value
1
BIPC icon
Brookfield Infrastructure
BIPC
+$1.03M
2
OXLC
Oxford Lane Capital
OXLC
+$1,000K
3
ECC
Eagle Point Credit Company
ECC
+$951K
4
ORAN
Orange
ORAN
+$441K
5
SNP
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
+$424K

Top Sells

Rank Stock Value
1
DKL icon
Delek Logistics
DKL
+$2.13M
2
WES icon
Western Midstream Partners
WES
+$888K
3
CNXM
CNX Midstream Partners LP
CNXM
+$744K
4
OSB
Norbord Inc.
OSB
+$695K
5
MPC icon
Marathon Petroleum
MPC
+$594K

Sector Composition

Rank Sector Weight
1 Healthcare 32.34%
2 Real Estate 18.02%
3 Energy 12.43%
4 Materials 10.7%
5 Financials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VNDA icon
126
Vanda Pharmaceuticals
VNDA
$307M
$529K 0.28%
54,777
+4,614
+9% +$49.3K
JQC icon
127
Nuveen Credit Strategies Income Fund
JQC
$704M
$528K 0.28%
89,308
-16,198
-15% -$97K
ACAD icon
128
Acadia Pharmaceuticals
ACAD
$4.46B
$526K 0.28%
12,748
+1,074
+9% +$46.4K
SRPT icon
129
Sarepta Therapeutics
SRPT
$1.62B
$517K 0.27%
3,679
+310
+9% +$47.1K
GBT
130
DELISTED
Global Blood Therapeutics, Inc.
GBT
$514K 0.27%
9,328
+786
+9% +$50K
KPTI icon
131
Karyopharm Therapeutics
KPTI
$160M
$511K 0.27%
2,333
+196
+9% +$47.9K
UTHR icon
132
United Therapeutics
UTHR
$26.1B
$511K 0.27%
5,064
+427
+9% +$46.9K
LGND icon
133
Ligand Pharmaceuticals
LGND
$5.96B
$510K 0.27%
8,582
+722
+9% +$49.3K
GILD icon
134
Gilead Sciences
GILD
$166B
$505K 0.26%
7,992
+680
+9% +$47.2K
CLVS
135
DELISTED
Clovis Oncology, Inc.
CLVS
$504K 0.26%
86,459
+7,282
+9% +$43.6K
RDUS
136
DELISTED
Radius Health, Inc.
RDUS
$504K 0.26%
44,481
+3,747
+9% +$46.3K
NMFC icon
137
New Mountain Finance
NMFC
$665M
$503K 0.26%
52,605
-25,147
-32% -$243K
MRTX
138
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$501K 0.26%
3,020
-404
-12% -$55.3K
ESPR
139
DELISTED
Esperion Therapeutics
ESPR
$500K 0.26%
13,442
+1,132
+9% +$44.8K
NBIX icon
140
Neurocrine Biosciences
NBIX
$18.3B
$490K 0.26%
5,091
+284
+6% +$32.9K
TGTX icon
141
TG Therapeutics
TGTX
$8.37B
$480K 0.25%
17,921
-2,461
-12% -$56.6K
HTGC icon
142
Hercules Capital
HTGC
$3.04B
$475K 0.25%
41,042
-5,064
-11% -$56.3K
IONS icon
143
Ionis Pharmaceuticals
IONS
$8.94B
$475K 0.25%
10,013
+843
+9% +$46.8K
NKTR icon
144
Nektar Therapeutics
NKTR
$2.39B
$473K 0.25%
1,902
+161
+9% +$50.6K
RAPT
145
DELISTED
RAPT Therapeutics
RAPT
$461K 0.24%
1,790
-244
-12% -$54.2K
BGX
146
Blackstone Long-Short Credit Income Fund
BGX
$135M
$456K 0.24%
35,437
-13,691
-28% -$171K
DNLI icon
147
Denali Therapeutics
DNLI
$3.81B
$447K 0.23%
12,464
-1,710
-12% -$51.5K
MYOK
148
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$447K 0.23%
3,282
-439
-12% -$46.7K
BGB
149
Blackstone Strategic Credit 2027 Term Fund
BGB
$499M
$444K 0.23%
36,328
-14,092
-28% -$166K
XBIT icon
150
XBiotech
XBIT
$69.2M
$442K 0.23%
23,176
-3,164
-12% -$54.6K
4 5
6
7 8

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2020 Portfolio in Review

As of Q3 2020, Virtus ETF Advisers held 450 positions worth $191M, down 9.7% from $211M the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Virtus ETF Advisers withdrew a net $12.4M in Q3 2020, closing 125 positions and reducing 215 holdings. Its most notable exit was CNX Midstream Partners LP, an estimated $744K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Real Estate and Energy.

Against the trend, Virtus ETF Advisers opened a new position in Oxford Lane Capital worth $1.03M.

  • Virtus ETF Advisers's largest Q3 2020 buy was Oxford Lane Capital: 46,671 shares worth $1.03M.
  • Virtus ETF Advisers added most to Brookfield Infrastructure in Q3 2020, an estimated $1.03M increase.
  • Virtus ETF Advisers's biggest Q3 2020 reduction was Delek Logistics, cutting an estimated $2.13M.
  • Virtus ETF Advisers fully exited CNX Midstream Partners LP in Q3 2020, selling an estimated $744K.
  • Virtus ETF Advisers's ten largest holdings make up 8% of its $191M portfolio in Q3 2020.
  • Virtus ETF Advisers opened 8 new positions and closed 125 in Q3 2020.
  • Virtus ETF Advisers's portfolio value fell 9.7% quarter-over-quarter to $191M.

Based on Virtus ETF Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.